Jean-Charles SORIA

Jean-harles Soria: is Amgen’s senior vice president of Oncology within Global Development. Soria joins Amgen from Institut Gustave Roussy, where he was appointed director general by France’s minister of health and solidarity.

Soria is a medical oncologist and professor of medicine at Paris-Saclay University. He holds a doctorate in molecular biology.

He completed his training during a two-year appointment at the MD Anderson Cancer Center in Houston, Texas, U.S., where he was an associate professor from 2013 to 2017. He also served at the director of the Gustave Roussy SIRIC Socrate (Integrated Cancer Research Site) from 2012 to 2017.

From 2017 to 2019 he held the role of senior vice president, Research and Development in Oncology, with AstraZeneca in Gaithersburg, Maryland, U.S., where he led research teams responsible for strategy and for development of new agents in immuno-oncology, cell therapy and conjugated antibodies. Additionally, he has authored or co-authored more than 670 articles in leading international journals and has appeared on lists of the most influential research scientists in the world.

PEGASCY governance

Founders

MD, phD
 

Jean-harles Soria: is Amgen’s senior vice president of Oncology within Global Development. Soria joins Amgen from Institut Gustave Roussy

Jean-Charles

SORIA

Chief Executive Officer
 

Jean-Pierre Armand MD, MSc, is certified in Medical Oncology (University of Toulouse III and Paris XI). He was recently General Director of the Institut Claudius Regaud in Toulouse.

Jean-Pierre

ARMAND

MD, phD
 

Fabrice André: Director of Research at Gustave Roussy since February 2020, Prof. Fabrice André coordinates the Institute's medical-scientific research programs, in conjunction with the Medical Director.

Fabrice

ANDRÉ

 

MD, phD
 

Aurelie Marabelle: MD, PhD, is a Senior Medical Oncologist in the Drug Development Department (DITEP), a group leader in Prof Laurence Zitvogel’s lab (INSERM U1015)

Aurélien

MARABELLE

MBA
 

Sébastien Bazin: After five years working in several financial positions in New York, San Francisco and London

Sébastien

BAZIN

MBA
 

Thierry Bruhat: he spent more than 20 years in supporting innovation projects and policies based on cooperation between companies, research

Thierry

BRUHAT

Board

Chairman
 

Jean-Pierre Armand MD, MSc, is certified in Medical Oncology (University of Toulouse III and Paris XI). He was recently General Director of the Institut Claudius Regaud in Toulouse.

Jean-Pierre

ARMAND

Censor
 

Sébastien Bazin: After five years working in several financial positions in New York, San Francisco and London

Sebastien

BAZIN

Directors
 

Fabrice Barlesi: As a specialist in lung cancer, precision medicine and cancer immunology

Fabrice

BARLESI

Directors
 

Olivier Edwards: is a lawyer who advises emerging companies and venture capital funds on investment, merger & acquisition matters with an emphasis on cross-border deals.

Olivier

EDWARDS

COO/CFO
 

Jean-Paul Alves, BSc in Economy, Graduated from EM Lyon and Post Graduated in Managerial Accounting, Chartered Accounting and Tax, joined Pegascy in 2020 as Chief Financial Officer.

Jean-Paul

ALVES